GPhA Statement on the Generic Drug User Fee Amendments
August 31st 2016The Food and Drug Administration (FDA) and the generic drug manufacturing industry including representatives of generic pharmaceutical manufacturers, active pharmaceutical ingredient manufacturers and contract manufacturing organizations have reached agreement on a package of program enhancements and resource commitments to reauthorize the Generic Drug User Fee Amendments of 2012 (GDUFA), which are set to expire next year.
Read More
Do SAMe Supplements Work in Depression?
August 30th 2016The burgeoning body of evidence supporting complementary and alternative medicine (CAM) for depression should encourage providers to employ it in patients with mild-to-moderate disease and those resistant to pharmacologic and psychologic therapies.
Read More
Universities, professional organisations and authorities around the world have been enabled to take steps towards ensuring that pharmacists are capable and competent thanks to resources produced by FIP Education (FIPEd), the International Pharmaceutical Federation (FIP) has found.
Read More